Initially, Amvuttra’s annual list price will be nearly double the yearly cost of rival medicines from Pfizer and BridgeBio.

The FDA approval of Alnylam’s Amvuttra sets up a three-way race with Pfizer and BridgeBio, which both market transthyretin ...

Despite growing competition in the transthyretin amyloid cardiomyopathy (ATTR-CM) field, Alnylam is hoping its RNA ...

Nevertheless, analysts expect Alnylam to claim about 80% of the market ... “The results from the NEURO-TTR study support a favourable benefit-risk profile for inotersen in patients with hATTR.

Eurasia Mining Plc, a mining and mineral exploration company, engages in the exploration, development, and production of palladium, platinum, rhodium, iridium, copper ...

In stark contrast with Carvalho’s science-driven approach, delegates are being forced to address The Metals Company's (TMC) threat to submit the world’s first ever deep sea mining application for the ...

The company's principal asset is the Madaouela project which holds 80% interest located in north-central Niger. It also owns 100% interest in the Muntanga project that consists of 3 mining ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

Alnylam Pharmaceuticals (NASDAQ: NASDAQ:ALNY) stock climbed 5% as trading resumed on Friday morning, following the company’s announcement that the FDA has approved AMVUTTRA for treating ATTR ...

To allocate 60% of investments to growth assets such as shares, property and infrastructure securities and 40% to defensive assets such as fixed interest and cash. In order to provide additional ...

PRICE INCLUDES FREIGHT AND PDI. There's no better way to build confidence than with a TT-R! Designed with new riders in mind, the TT-R 125 features lightweight construction, electric start, and smooth ...